- Home
- UBX vs BBGI Comparison
UBX vs BBGI Comparison
Compare UBX & BBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- BBGI
- Stock Information
- Founded
- UBX 2009
- BBGI 1961
- Country
- UBX United States
- BBGI United States
- Employees
- UBX N/A
- BBGI N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- BBGI Broadcasting
- Sector
- UBX Health Care
- BBGI Consumer Discretionary
- Exchange
- UBX Nasdaq
- BBGI Nasdaq
- Market Cap
- UBX 16.5M
- BBGI 13.2M
- IPO Year
- UBX 2018
- BBGI 2000
- Fundamental
- Price
- UBX $1.73
- BBGI $8.27
- Analyst Decision
- UBX Strong Buy
- BBGI
- Analyst Count
- UBX 2
- BBGI 0
- Target Price
- UBX $7.00
- BBGI N/A
- AVG Volume (30 Days)
- UBX 303.9K
- BBGI 7.9K
- Earning Date
- UBX 11-04-2024
- BBGI 02-10-2025
- Dividend Yield
- UBX N/A
- BBGI N/A
- EPS Growth
- UBX N/A
- BBGI N/A
- EPS
- UBX N/A
- BBGI 1.69
- Revenue
- UBX N/A
- BBGI $238,754,777.00
- Revenue This Year
- UBX N/A
- BBGI $2.55
- Revenue Next Year
- UBX $33.62
- BBGI N/A
- P/E Ratio
- UBX N/A
- BBGI $4.90
- Revenue Growth
- UBX N/A
- BBGI N/A
- 52 Week Low
- UBX $0.94
- BBGI $7.60
- 52 Week High
- UBX $2.02
- BBGI $18.80
- Technical
- Relative Strength Index (RSI)
- UBX 63.32
- BBGI 41.01
- Support Level
- UBX $1.56
- BBGI $8.20
- Resistance Level
- UBX $1.85
- BBGI $9.46
- Average True Range (ATR)
- UBX 0.22
- BBGI 0.43
- MACD
- UBX 0.05
- BBGI -0.06
- Stochastic Oscillator
- UBX 75.96
- BBGI 4.61
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The Company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. The Company owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The Company currently operates three operating segments Audio, Digital and esports.